Literature DB >> 15995345

The pleiotropy of telomerase against cell death.

Young Hoon Sung1, Yoon Sik Choi, Cheolho Cheong, Han-Woong Lee.   

Abstract

The end of eukaryotic genomic DNA is capped by a specialized structure called as "telomere", which consists of the repetitive array of nucleotide sequence, TTAGGG, in humans and mice, and a variety of binding proteins. Telomerase is a ribonucleoprotein (RNP) complex responsible for the elongation of telomeres to maintain the genomic integrity, and is composed of telomerase reverse transcriptase (TERT), telomerase RNA component (TERC), and their associated factors regulating the catalytic activity of telomerase. Although it is now apparent that telomerase protects cells from apoptosis via the maintenance of genomic integrity by stabilizing telomeres, our understanding for the physiological role of telomerase is yet far from completion, and emerging evidence suggests that telomerase has additional extratelomeric roles in mediating cell survival and anti-apoptotic functions against various cytotoxic stresses. Here we summarize and discuss how telomerase and telomeres are involved in mediating cellular protection against apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15995345

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  12 in total

Review 1.  Telomerase and the aging process.

Authors:  Peter J Hornsby
Journal:  Exp Gerontol       Date:  2007-03-30       Impact factor: 4.032

2.  p53 and hTERT determine sensitivity to viral apoptosis.

Authors:  Marie L Nguyen; Rachel M Kraft; Martine Aubert; Edward Goodwin; Daniel DiMaio; John A Blaho
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 3.  Improving cell therapy--experiments using transplanted telomerase-immortalized cells in immunodeficient mice.

Authors:  Qin Huang; Meizhen Chen; Sitai Liang; Victor Acha; Dan Liu; Furong Yuan; Christina L Hawks; Peter J Hornsby
Journal:  Mech Ageing Dev       Date:  2006-11-22       Impact factor: 5.432

4.  Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response.

Authors:  O M Wolkowitz; S H Mellon; E S Epel; J Lin; V I Reus; R Rosser; H Burke; M Compagnone; J C Nelson; F S Dhabhar; E H Blackburn
Journal:  Mol Psychiatry       Date:  2011-01-18       Impact factor: 15.992

Review 5.  Physiological assembly and activity of human telomerase complexes.

Authors:  Kathleen Collins
Journal:  Mech Ageing Dev       Date:  2007-10-30       Impact factor: 5.432

6.  Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions.

Authors:  W Giaretti; M Maffei; M Pentenero; P Scaruffi; A Donadini; E Di Nallo; D Malacarne; R Marino; U Familiari; S Coco; G P Tonini; P Castagnola; S Gandolfo
Journal:  Cell Oncol (Dordr)       Date:  2011-12-06       Impact factor: 6.730

7.  Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis.

Authors:  Erez Eitan; Ailon Tichon; Aviv Gazit; Daniel Gitler; Shimon Slavin; Esther Priel
Journal:  EMBO Mol Med       Date:  2012-02-20       Impact factor: 12.137

8.  Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism.

Authors:  P Phatak; J C Cookson; F Dai; V Smith; R B Gartenhaus; M F G Stevens; A M Burger
Journal:  Br J Cancer       Date:  2007-04-03       Impact factor: 7.640

9.  Aspirin inhibits human telomerase activation in unstable carotid plaques.

Authors:  Fangming Li; Yi Guo; Xin Jiang; Jianxin Zhong; Guandong Li; Shenggang Sun
Journal:  Exp Ther Med       Date:  2013-04-29       Impact factor: 2.447

10.  Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells.

Authors:  Zhengpei Zhang; Ling Yu; Guo Dai; Kezhou Xia; Gaiwei Liu; Qi Song; Chunjie Tao; Tian Gao; Weichun Guo
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.